Methionine sulfoximine supplementation enhances productivity in GS-CHOK1SV cell lines through glutathione biosynthesis.
In Lonza Biologics' GS Gene Expression System™, recombinant protein-producing GS-CHOK1SV cell lines are generated by transfection with an expression vector encoding both GS and the protein product genes followed by selection in MSX and glutamine-free medium. MSX is required to inhibit endogenous CHOK1SV GS, and in effect create a glutamine auxotrophy in the host that can be complemented by the expression vector encoded GS in selected cell lines. However, MSX is not a specific inhibitor of GS as it also inhibits the activity of GCL (a key enzyme in the glutathione biosynthesis pathway) to a similar extent. Glutathione species (GSH and GSSG) have been shown to provide both oxidizing and reducing equivalents to ER-resident oxidoreductases, raising the possibility that selection for transfectants with increased GCL expression could result in the isolation of GS-CHOKISV cell lines with improved capacity for recombinant protein production. In this study we have begun to address the relationship between MSX supplementation, the amount of intracellular GCL subunit and mAb production from a panel of GS-CHOK1SV cell lines. We then evaluated the influence of reduced GCL activity on batch culture of an industrially relevant mAb-producing GS-CHOK1SV cell line. To the best of our knowledge, this paper describes for the first time the change in expression of GCL subunits and recombinant mAb production in these cell lines with the degree of MSX supplementation in routine subculture. Our data also shows that partial inhibition of GCL activity in medium containing 75 µM MSX increases mAb productivity, and its more specific inhibitor BSO used at a concentration of 80 µM in medium increases the specific rate of mAb production eight-fold and the concentration in harvest medium by two-fold. These findings support a link between the inhibition of glutathione biosynthesis and recombinant protein production in industrially relevant systems and provide a process-driven method for increasing mAb productivity from GS-CHOK1SV cell lines. © 2016 American Institute of Chemical Engineers Biotechnol. Prog., 33:17-25, 2017.
New Expression Technologies Group, Research and Technology, Lonza Biologics, Granta Park, Cambridge, CB21 6GS, U.K.
Marc
M
Feary
Future Technologies, Research and Technology, Lonza Biologics, Slough, SL1 4DX, U.K.
Andrew J
AJ
Racher
New Expression Technologies Group, Research and Technology, Lonza Biologics, Granta Park, Cambridge, CB21 6GS, U.K.
Robert J
RJ
Young
Centre for Industrial Biotechnology and School of Biosciences, University of Kent, Canterbury, CT2 7NJ, U.K.
C Mark
CM
Smales
D000818:Animals; D000911:Antibodies, Monoclonal / Q000096:biosynthesis*; D061249:Batch Cell Culture Techniques / Q000379:methods; D019328:Buthionine Sulfoximine / Q000737:chemistry; D016466:CHO Cells; D018929:Cell Culture Techniques / Q000379:methods*; D006224:Cricetinae; D003412:Cricetulus; D003470:Culture Media / Q000737:chemistry; D005974:Glutamate-Ammonia Ligase / Q000378:metabolism*; D005973:Glutamine / Q000737:chemistry; D005978:Glutathione / Q000096:biosynthesis*; D008717:Methionine Sulfoximine / Q000378:metabolism; D011994:Recombinant Proteins / Q000096:biosynthesis*; D014162:Transfection
D000911:Antibodies, Monoclonal; D003470:Culture Media; D011994:Recombinant Proteins; D005973:Glutamine; D008717:Methionine Sulfoximine; D019328:Buthionine Sulfoximine; D005974:Glutamate-Ammonia Ligase; D005978:Glutathione
CHO cells; bioprocess development; buthionine sulfoximine; gene expression systems; glutamine synthetase; glutathione; industrial biotechnology; methionine sulfoximine